Research and Development

The Hospital has a very active Diabetes Team focusing on research and education for patients and their families with diabetes. There is an active academic and research fund which aims to fund raise to provide the support for patients in the community.

Diabetes affects 1 in 20 people in the local community. The award winning Diabetes Team at the George Eliot aims to reduce new cases of diabetes in the local community, develop research into the condition and improve the care of patients with diabetes, to reduce complications such as heart disease, stroke, blindness and kidney failure.

Another good example that supports research and development and brings them closer to clinical areas is the Lymphodema trials that we currently have at the George Eliot.

Kay Hill from the Mary Ann Evans Hospice comments:
Kay says : "What we're doing is something we've never done before, joint working with the George Eliot and the hospice and we're measuring patients before they have auxiliary node clearance. Anybody who measures an increase will be forwarded to the trial so early treatment leads to a better response and hopefully no long term complications from lymphoedema."

Kay comments on the relationship between the Trust and the Mary Ann Evans Hospice:
"It's really good being involved in the research. It's really opened up pathways and also I think generally the hospice and the George Eliot are doing more integrated working."

Kath Kelly our Chief Executive comments on the relationship with the Hospice:
"I am pleased that research is really at the heart of what we're trying to do in terms of excelling at the care that we give our patients. Our team here is led by Dr Loay David and supported by Emma  Brannan who is the manager in the research department. It's about doing things that allow us to learn more about conditions and treatments that will have a positive outcome on patient care."